Permanent Left Bundle Branch Area DF‐4 Defibrillator Lead Implantation—Feasibility, Procedural Caveats, Safety, and Follow‐Up
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.16585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Anindya Ghosh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Electrophysiology and Pacing, Arrhythmia Heart Failure Academy, The Madras Medical Mission, Chennai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Electric Countershock. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Introduction
Permanent implantation of a DF‐4 implantable cardiac defibrillator (ICD) lead in the left bundle branch area (LBBA‐ICD) is the next paradigm in amalgamating cardiac resynchronization therapy (CRT) and defibrillation. We systematically investigated feasibility/success rate, procedural caveats, and complications associated with a permanent DF‐4 LBBA ICD implant and pertinent data at short‐term follow‐up.
Methods
We prospectively attempted implantation of 7 Fr Durata (Abbott, Chicago, IL, USA) single coil DF‐4 ICD lead at the LBBA using a fixed‐curve non‐deflectable CPS locator delivery sheath. Standard criteria defined LBBA capture. Relevant sensing/pacing, defibrillation, radiographic, and echocardiographic parameters testing were recorded at implant, discharge and 5‐month follow‐up.
Results
We enrolled 12 consecutive cardiac device‐naïve patients (median age 67.5 years, male 91.7%, median LVEF 30%, median septal thickness 9 mm, median QRS duration 140 ms, class I CRT indication 58.3%, primary prevention ICD indication 75%). Minor complications (two transeptal perforations and one micro‐dislodgment) were noted in 3/12 (25%) patients. Successful permanent LBBA ICD implant with adequate sensing/pacing was achieved in 9/12 (75%) subjects. Sustained ventricular fibrillation (VF) was inducible in 7/9 patients with successful implants with effective sensing and defibrillation in all. Follow‐up device‐related and echocardiographic parameters were similar at discharge and 5‐month follow‐up.
Conclusion
Permanent DF‐4 LBBA ICD implant is feasible and successful in 75% of patients with an indication for ICD. With dedicated toolkits, higher volumes, and an obligate learning curve, the higher‐than‐expected frequency (25%) of minor complications may be ameliorated. Short‐term data regarding lead and selected RV parameters remained favorable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Electrophysiology and Pacing, Arrhythmia Heart Failure Academy, The Madras Medical Mission, Chennai, Tamil Nadu, India.
- Division of Cardiology, Sub-Section of Electrophysiology, Children's Hospital of Michigan and Detroit Medical Center, Detroit, Michigan, USA.
- Department of Medicine, Section of Cardiology, The University of Chicago Medicine, Center for Arrhythmia Care, Pritzker School of Medicine, Chicago, Illinois, USA.
ORCID-Profile: Anindya Ghosh, Chenni S Sriram
Zitieren
APA
Ghosh, A., Sriram, C. S., Manu, N., Sankaradas, M. A., Upadhyay, G. M., & Pandurangi, U. M. (2025). Permanent Left Bundle Branch Area DF‐4 Defibrillator Lead Implantation—Feasibility, Procedural Caveats, Safety, and Follow‐Up. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16585
Vancouver
Ghosh A, Sriram CS, Manu N, Sankaradas MA, Upadhyay GM, Pandurangi UM. Permanent Left Bundle Branch Area DF‐4 Defibrillator Lead Implantation—Feasibility, Procedural Caveats, Safety, and Follow‐Up. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16585
BibTeX
@article{Ghosh2025,
author = {Ghosh, Anindya and Sriram, Chenni S and Manu, Nibin and Sankaradas, Mullasari Ajit and Upadhyay, Gaurav M and Pandurangi, Ulhas M},
title = {Permanent Left Bundle Branch Area DF‐4 Defibrillator Lead Implantation—Feasibility, Procedural Caveats, Safety, and Follow‐Up},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.16585}
}
EUVIMED